DRUG · Unmapped registry intervention
Batefenterol + Fluticasone Furoate
Find medicine records ·
Find other trials using this name
Clinical trial
Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
NCT02573870
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Albuterol
Normalized identity: albuterolView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBatefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Interventions
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02573870 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.